Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP538783.RAvzUnfTWabogykVIg5CWvLCBGbGxggNJRW54TAJ5TOeA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP538783.RAvzUnfTWabogykVIg5CWvLCBGbGxggNJRW54TAJ5TOeA130_assertion type Assertion NP538783.RAvzUnfTWabogykVIg5CWvLCBGbGxggNJRW54TAJ5TOeA130_head.
- NP538783.RAvzUnfTWabogykVIg5CWvLCBGbGxggNJRW54TAJ5TOeA130_assertion description "[We describe for the first time that high levels of LOXL2 are associated with decreased overall and disease-free survival in laryngeal squamous cell carcinomas, lung squamous cell carcinoma, and lymph node-negative (N(0)) breast adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP538783.RAvzUnfTWabogykVIg5CWvLCBGbGxggNJRW54TAJ5TOeA130_provenance.
- NP538783.RAvzUnfTWabogykVIg5CWvLCBGbGxggNJRW54TAJ5TOeA130_assertion evidence source_evidence_literature NP538783.RAvzUnfTWabogykVIg5CWvLCBGbGxggNJRW54TAJ5TOeA130_provenance.
- NP538783.RAvzUnfTWabogykVIg5CWvLCBGbGxggNJRW54TAJ5TOeA130_assertion SIO_000772 18559498 NP538783.RAvzUnfTWabogykVIg5CWvLCBGbGxggNJRW54TAJ5TOeA130_provenance.
- NP538783.RAvzUnfTWabogykVIg5CWvLCBGbGxggNJRW54TAJ5TOeA130_assertion wasDerivedFrom befree-20150227 NP538783.RAvzUnfTWabogykVIg5CWvLCBGbGxggNJRW54TAJ5TOeA130_provenance.
- NP538783.RAvzUnfTWabogykVIg5CWvLCBGbGxggNJRW54TAJ5TOeA130_assertion wasGeneratedBy ECO_0000203 NP538783.RAvzUnfTWabogykVIg5CWvLCBGbGxggNJRW54TAJ5TOeA130_provenance.